Overview
Join a Hidradenitis Suppurativa Research Study!
Hidradenitis suppurativa (HS) is a painful, long-term skin condition that causes skin abscesses and scarring on the skin.
Hidradenitis suppurativa (HS) primarily manifests as painful, inflamed lumps or nodules, often with pus-filled abscesses, that can break open and drain fluid.
This study is researching a non-opioid investigational drug that is being developed for pain management associated with Hidradenitis Suppurativa (HS).
By joining as a volunteer, you play a key role in making these important advancements possible.
Sign up to see if you qualify!
About this Study
PERIOD TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF TIBULIZUMAB IN ADULTS WITH HIDRADENITIS SUPPURATIVA / 2 part study with Open Label extension
The trial is evaluating an investigational medication as a possible treatment for Hidradenitis Suppurativa (HS).
Your participation in clinical research is critical to helping researchers discover new ways to potentially treat pain from Hidradenitis Suppurativa (HS).
Who Can Join
To be eligible, you must:
- Be 18 – 70 years old
- Have history of Hidradenitis Suppurativa (HS) symptoms for at least 6 months (diagnosis not needed)
- Have at 5 lesions on at least 2 parts of the body
- Have had an appropriate course of oral antibiotics for the treatment of HS but:
- had an inadequate response, OR
- demonstrated intolerance, OR
- had a contraindication, OR
- exhibited recurrence after discontinuation
You must not have used any of the following:
- Immunosuppressants
- Any prior use of anti-IL-17 or anti-BAFF therapies
- B cell-depleting biologics within 12 months
- Marketed (e.g., adalimumab) or investigational biological agents within 12 weeks
- Systemic non-biologic therapies that could affect HS within past 4 weeks, including, but not limited to:
* Methotrexate
* Cyclosporine
* Retinoids
* Janus kinase (JAK) inhibitors
* Bruton’s tyrosine kinase (BTK) inhibitors
* Fumaric acid esters
* Oral or injectable corticosteroids
*Other conditions apply
Not sure if you qualify? That’s okay.
A member of our recruitment team will review your medical history and medications with you to see if this study may be right for you.
What to Expect
Study Duration:
Up to 44 weeks
Study Visits:
Up to 9 site visits
Compensation:
Participants may receive compensation up to $1475